CClinicalTrials.gg
CompletedNCT01401374Updated Apr 10, 2017

Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

An observational study in Vitiligo Vulgaris, sponsored by St. Luke's-Roosevelt Hospital Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2017-04-10.

Sponsored by St. Luke's-Roosevelt Hospital Center · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
3,258
Sex
All
01

Study summary

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Read the detailed description

The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.

02

Conditions studied

  • Vitiligo Vulgaris

Browse trials for

Keywords

  • Vitiligo Vulgaris
  • Autoimmunity
  • Thyroid Disease
03

In context

Vitiligo

298 studies on the registry are indexed under Vitiligo; 69 are open to participants now.

This study's enrollment of 3,258 is above the median of 111 across 60 observational studies indexed under Vitiligo.

Browse Vitiligo studies →

Lead sponsor

St. Luke's-Roosevelt Hospital Center is the lead sponsor of 68 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris

Inclusion criteria

  • Ability to complete survey

Exclusion criteria

Exclusion Criteria:

  • Inability to complete survey
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
3,258 participants (actual)

Groups and cohorts

  • Vitiligo Patients

    patients with vitiligo vulgaris

  • Controls

    Individuals without vitiligo vulgaris

06

What researchers measure

Primary outcomes

  1. Correlation of Disease State in Vitiligo with Clinical and Psychological Measures

    Time frame: Self-reported retrospective single survey

07

Study locations

1 site
  • St. Luke's-Roosevelt Hospital Center
    New york, New York 10025, United States
08

References and documents

Publications

  • Silverberg JI, Reja M, Silverberg NB. Regional variation of and association of US birthplace with vitiligo extent. JAMA Dermatol. 2014 Dec;150(12):1298-305. doi: 10.1001/jamadermatol.2014.899. PubMed 25006795 ↗
  • Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014 May-Jun;31(3):309-18. doi: 10.1111/pde.12226. Epub 2013 Oct 18. PubMed 24304125 ↗
  • Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013 Feb;149(2):159-64. doi: 10.1001/jamadermatol.2013.927. PubMed 23560296 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01401374
Lead sponsor
St. Luke's-Roosevelt Hospital Center
Responsible party
Sponsor
First posted
Jul 25, 2011
Start date
Mar 2011
Primary completion
Mar 2016
Completion
Mar 2016
Last update
Apr 10, 2017

Study contacts

Nanette Silverberg, MD
principal investigator · St. Luke's-Roosevelt Hospital Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion